Close Menu

NEW YORK – Microbiology testing and diagnostics firm PathoQuest today announced the closing of an €8 million ($8.9 million) financing round.

The funding includes a loan from Norgine Ventures and financing from previous investors Kurma Partners, Idinvest Partners, and Charles River Labs, as well as new investor Investiere.

The money includes €427,000 in non-dilutive funding from the French public investment program Investissement d'Avenir concours d'innovation i-Nov.

Other details, including PathoQuest's intended use of the funds, were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.

According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.

New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.

In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.